Oral Presentations 49: Drug Discovery 9 (Natural Products)
Tracks
Track 1
| Friday, July 17, 2026 |
| 9:00 AM - 10:30 AM |
Speaker
Assoc Prof Maha Abdollah
The British University In Egypt
Dr Rani Wardani Hakim
Faculty Of Medicine/Universitas Indonesia
Assist Prof Hui-Ming Chen
Academia Sinica
Medicinal Plant-derived Agents Enhance Anti-tumor Memory Immunity in Advanced Melanoma
Biography
Dr. Chen is an Assistant Research Fellow at the Agricultural Biotechnology Research Center, Academia Sinica. After starting her career as a pharmacist, she earned her Ph.D. from the Institute of Pharmacology at National Yang Ming Chiao Tung University. Before joining Academia Sinica, she was a research scientist at the Immunotherapy Research Center at Houston Methodist Research Institute. Drawing on her interdisciplinary expertise in pharmacy, pharmacology, and immunology, Dr. Chen’s research aims to connect basic scientific discovery with translational applications. Her primary focus is on developing new immunotherapies and natural product-based therapeutics. Her team investigates the biology of pathological myeloid cells—specifically how they interact with other cells in the tumor microenvironment and their role in subsequent immune responses. A significant area of her work involves studying these myeloid cells in the context of persistent inflammation, which is common in conditions like cancer and aging. Furthermore, Dr. Chen has identified several medicinal plant-derived products as potential myeloid-targeted phyto-medicines, offering promising directions for new drug development and immunomodulatory and nutritional therapies.
Mr Silviu Iulian Filipiuc
Grigore T. Popa University Of Medicine And Pharmacy Iasi
Dr Leontina-Elena Filipiuc
Grigore T. Popa University of Medicine and Pharmacy Iasi
Dr Osama Abusara
Associate Professor of Pharmacology
Al-Zaytoonah University of Jordan
Anticancer activity of marine sponge’s ethanolic extract on lung cancer cells
Biography
Dr. Osama H. Abusara is an Associate Professor of Pharmacology at the Department of Pharmacy at Al-Zaytoonah University of Jordan (ZUJ), Jordan. He has been working at ZUJ since 2017. Dr. Abusara obtained his Ph.D. degree in Pharmacy and Pharmaceutical Sciences from the University of Manchester, UK, in 2017 and his B.Sc. degree in Pharmacy from the University of Jordan, Jordan, in 2014. Dr. Abusara’s research interests include investigating novel compounds for cancer treatments, repurposing existing drugs for cancer treatment, molecular cancer, and peptide synthesis. He also collaborates with researchers of different pharmaceutical fields. Dr. Abusara has authored and co-authored more than 30 published papers in leading scientific journals. Dr. Abusara is a member of the Jordanian Pharmacists Association since 2014.